argenx SE
XBRU:ARGX

Watchlist Manager
argenx SE Logo
argenx SE
XBRU:ARGX
Watchlist
Price: 569.6 EUR Market Closed
Market Cap: 34.1B EUR
Have any thoughts about
argenx SE?
Write Note

P/FCFE
Price to FCFE

-108.8
Current
-25.9
Median
27.3
Industry
Lower than median
Lower than industry value

Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

P/FCFE
-108.8
=
Market Cap
34.1B EUR
/
FCFE
-330.7m USD
All Countries
Close
 
NL
argenx SE
XBRU:ARGX
Average P/FCFE: 31.6
Negative Multiple: -108.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -3 183 345.6
US
Abbvie Inc
NYSE:ABBV
12
US
Amgen Inc
NASDAQ:AMGN
26.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -90.6
US
Gilead Sciences Inc
NASDAQ:GILD
11.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -431
AU
CSL Ltd
ASX:CSL
80.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
26.6
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -718.1

P/FCFE Forward Multiples

Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/FCFE
N/A
2-Years Forward
P/FCFE
N/A
3-Years Forward
P/FCFE
N/A

See Also

Discover More